Diagnostics and medicines are becoming more targeted.

Individualised treatments require cost-effective and targeted approaches to preparing and sampling genetic material and the isolation of specific cells of interest.

Our expertise in microfluidics, single-cell analysis and manipulation, along with experience in deep imaging and data analysis experience enable our clients to create patient-specific therapies. 

As more specific and complex diagnostic pathways migrate from research use only (RUO) to in-vitro diagnostic (IVD) or point-of-care (POC) devices, complex lab-based procedures need to be replicated in standalone devices to meet the challenges of decentralised testing.

These systems are varied, but many require understanding of microfluidics and microdroplet manipulation, as well as techniques such as electrowetting, the introduction of shear forces and complex control systems.

Further systems require tight thermal controls, including the Polymerase Chain Reaction (PCR). 

The ability to monitor patients’ progress through frequent blood tests promises to revolutionise cancer treatment. Here, a blend of engineering, design and digital health expertise is helping clients lead the way in personalised medicine.

A track record developing complex medical devices gives us the experience to use powerful technologies – such as digital PCR and next-generation sequencing – and to create advanced liquid biopsy diagnostic platforms.   

Large amounts of genomic, molecular, cellular and patient data can be processed to accelerate the identification of new compounds, treatments, biological targets, pathways and clinical trial participants.

We can deploy world-class machine learning capabilities to develop practical systems for image and data analysis and the detection of patterns in voice, sleep and other physiological markers. 

Many companies start with a great life sciences idea then look for funding to develop it. Creating a compelling business case requires a clear understanding of the market need, the limitations of current products and the potential growth of the specific segment.

The strategy consulting team here specialises in primary and secondary market research, technical due diligence for acquisitions and compiling core business case information. Many clients carry out an initial study in order to support further funding rounds.

It is complex, so successful life science and diagnostic device development demands a diverse set of skills. We provide the experience and insight necessary to transform your ideas into fully-realised products ready for manufacture.

Engineering, biology and physics disciplines combine to form tight teams that develop and iterate complex solutions. These are tested in wet labs using biologically relevant models.

By complementing our clients’ own expertise and experience, we are better able to manage development risks. This results in increased confidence, reduced timelines and market-ready products.